Day 0 (at admission) | Day 13 (at HLH diagnosis) | At the 6th week after HLH treatment | Reference Range | |
---|---|---|---|---|
Parameters for HLH diagnosis | ||||
High fever | + | + | - | - |
Splenomegaly (under ribs, cm) | 4 | 4.5 | - | - |
Neutrophil count (×109/L) | 3.21 | 1.75 | 6.08 | 0.72–4.6 |
Platelet count (×109/L) | 139 | 89 | 116 | 100–400 × 109 |
Hemoglobin (g/L) | 82 | 76 | 284 | 110–190 |
Fibrinogen (g/L) | 2.2 | 1.24 | 2.44 | 2–4 |
Triglyceride (mmol/L) | 1.52 | 3.51 | 1.31 | 0–2 |
Serum ferritin (µg/L) | 175.7 | 269.6 | 163 | 28–397 |
Soluble CD25(pg/mL) | ND | 131,840 | 4117 | 0–6400 |
Hemophagocytosis in BM | - | ND | ND | - |
NK cell activity (%) | ND | 12.81 | 14.32 | >15.44 |
Other indicators | ||||
Neurological manifestations | + | +, deterioration | - | - |
CSF pressure (mmH2O) | 230 | >330 | ND | 40–100 |
CSF cell count (×106/L) | 30 | 45 | ND | 0–15 × 106 |
CSF Protein (mg/L) | 743 | 1216 | ND | 20–350 |
Head CT scan | Low density of brain parenchyma | Extensive lesions, cerebral edema, tonsil hernia | Greatly improved, cerebral edema (-) tonsil hernia (-) | - |
IFN-γ(pg/ml) | ND | 213.6 | 9.83 | 1.60–17.30 |
NK cell CD107a (%) | ND | 1.01 | 2.33 | >10 |
Infection, malignancy or autoimmune disease | - | - | ND | - |